July 31, 2018 Cell Analysis Tools Clinical Research/Diagn. Lab Top-10 PR/Corporate Product Launch

New Compounds Now Available for Antimicrobial Susceptibility Testing: Delafloxacin and Meropenem/Vaborbactam

FDA-cleared microbroth dilution plates provide true minimum inhibitory concentration (MIC) results, facilitating more targeted patient therapy CHICAGO – AACC – (July 31, 2018) – The antimicrobial delafloxacin, and the combination of meropenem and vaborbactam are now available on FDA-cleared microbroth dilution susceptibility plates. Delafloxacin is available for testing select fastidious and non-fastidious Gram positive and... Read more

July 31, 2018 Cell Analysis Tools Clinical Research/Diagn. Life Science Tools M&A, Partnerships

10x Genomics Partners with BioLegend and Immudex to Extend Research Applications of Its New Single Cell Feature Barcoding Technology

PLEASANTON, CA.—July 31, 2018—10x Genomics, Inc., a company focused on accelerating genomic discovery, today announced that BioLegend and Immudex will be the first 10x Compatible Partners providing products for its new single cell Feature Barcoding Technology, which was revealed at the 2018 Advances in Genome Biology and Technology meeting in February this year. The resulting product innovations, available at the end of... Read more

July 30, 2018 Bio/Pharma/CRO Clinical Research/Diagn. M&A, Partnerships

Forbes Insights and IDEX Health & Science LLC Report Finds Life Science Sector is ‘Behind’ the Collaboration Curve

Rohnert Park, CA, July 30, 2018 — A survey of three technology-intensive industries has found a growing share of executives, including 68% of life science executives, see active and meaningful collaboration with their suppliers as essential to their future success/innovation/competitive advantage. 180 executives from the life science, pharmaceuticals, and aviation industries took part in the... Read more

July 30, 2018 Acad, Gov/Utilities Clinical Research/Diagn. M&A, Partnerships

QIAGEN’s QuantiFERON-TB® Gold Plus wins UN migration agency’s tender

Hilden, Germany, and Germantown, Maryland, July 30, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that QuantiFERON-TB® Gold Plus (QFT-Plus), the gold standard in accurate, cost-effective testing for latent tuberculosis (TB) infection, has been adopted by the International Organization for Migration (IOM) for use in screening migrants for the infection. As the United... Read more

July 27, 2018 Clinical Research/Diagn. PR/Corporate

GNA Biosolutions named finalist for AACC’s Inaugural Disruptive Technology Award

Published on July 27, 2018. On July 30, 2018, GNA Biosolutions will be one of three finalists in the American Association of Clinical Chemistry’s (AACC) first-ever Disruptive Technology Award. GNA will be presenting data on the company’s proprietary Pulse Controlled Amplification (PCA) technology during a featured session at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo.... Read more

July 25, 2018 Clinical Research/Diagn. Licensing, IP, and Legal

Takara Bio granted manufacturing license from the Swedish Medical Product Agency for clinical-grade human embryonic stem cell line derivation and banking

MOUNTAIN VIEW, Calif., July 25, 2018 /PRNewswire/ — Takara Bio announced today that the Medical Products Agency (“MPA”), the Swedish national authority responsible for regulation and surveillance of the development, manufacturing and marketing of drug and other medical products, granted a manufacturing license for derivation and banking of human embryonic stem (hES) cells to be produced under GMP... Read more

July 24, 2018 Clinical Research/Diagn.

Roche Analyst Event on Diagnostics Division at AACC 2018: Tuesday, 31st July, 6:00pm CDT

Basel, 24 July 2018 Roche Analyst Event on Diagnostics Division at AACC 2018: Tuesday, 31st July, 6:00pm CDT Roche has held an analyst event on Tuesday, 31st July 2018 to discuss Roche’s Diagnostics Division, in conjunction with the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Exposition in Chicago, Illinois (July 30-August... Read more

July 24, 2018 Clinical Research/Diagn. M&A, Partnerships Mass Spectrometry

Agena Announces MassARRAY® Technology Selected for Participation in CANCER-ID Consortium

San Diego, CA, July 24, 2018 – Agena Bioscience, a global provider of molecular testing solutions, announced today that it has been selected for participation in the CANCER-ID Consortium.  Agena’s MassARRAY® System will support mutation detection from liquid biopsy samples as part of the consortium’s key work packages in lung cancer and breast cancer. “We are... Read more

July 24, 2018 Cell Analysis Tools Clinical Research/Diagn.

IsoPlexis Places IsoLight Single-Cell Proteomic Detection Instrument at Fred Hutchinson Cancer Research Center

The IsoLight is a first-of-its-kind system for high-throughput, single-cell functional proteomic detection BRANFORD, Conn., July 24, 2018 /PRNewswire/ — IsoPlexis Corporation (IsoPlexis), a privately held life sciences company at the forefront of single-cell analytics technology, has installed its ground-breaking IsoLight benchtop system at Fred Hutchinson Cancer Research Center, as part of the company’s Early Adopter Program. The sample-to-answer... Read more

July 20, 2018 Clinical Research/Diagn. Microscopy

“I’m working on something that could, one day, help cure my disease”

Researching Alport syndrome with ZEISS multibeam ion microscopy Customer Story Knowledge A ZEISS team in Peabody, USA is hard at work developing the multibeam ion microscope ZEISS ORION NanoFab. This instrument makes it possible to uncover kidney diseases that previously remained a mystery – a technique that can save lives. Technology connects Two colleagues from... Read more